Navigation Links
Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
Date:3/8/2013

WARSAW, Ind., March 8, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that its Board of Directors has approved the payment of an increased quarterly cash dividend to stockholders for the first quarter of 2013.  The new payment represents an increase of 11% over the dividend paid for the first quarter of 2012. 

"Zimmer is committed to returning considerable value to our stockholders through sales growth, operational excellence and disciplined capital allocation.  We are pleased that successful execution of our operational excellence agenda, coupled with our rigorous financial and operational discipline, has provided us with an opportunity to increase our dividend payment to stockholders for the first quarter of 2013," said David Dvorak, Zimmer President and CEO.  "The increase in our dividend also reflects our ongoing confidence in the Company's future and our capacity to generate cash and create value for our stockholders.  Throughout 2013, an extensive array of new product launches in our core reconstructive product categories and in new, adjacent categories will strengthen Zimmer's established leadership in musculoskeletal healthcare."  

The increased quarterly cash dividend of $0.20 per share will be paid on April 26, 2013, to stockholders of record as of the close of business on March 29, 2013.  Future declarations of dividends are subject to approval of the Board of Directors and may be adjusted as business needs or market conditions change.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical prod
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Zimmer Holdings to Present at Canaccord Genuitys Musculoskeletal Conference
2. Zimmer Holdings to Present at Barclays Capital 2013 Global Healthcare Conference
3. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
4. Zimmer Reports Fourth Quarter and 2012 Financial Results
5. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
6. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
7. Zimmer Holdings to Present at 24th Annual Piper Jaffray Healthcare Conference
8. Zimmer Launches Smartphone Comeback App Globally
9. Zimmer Holdings to Present at Credit Suisse 2012 Healthcare Conference
10. Zimmer Holdings, Inc. Reports Third Quarter 2012 Financial Results
11. Zimmer Holdings to Present at Morgan Stanley 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Medina Medical announced today that Mr. ... the Board of Directors on August 18, 2014. Mr. ... commercialization experience, including over a decade of direct experience ... a Partner of the medical device incubator The Foundry, ... Foundry start-ups. Mr. Engelson previously served as the Chief ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... 29, 2014 According to ... by Extraction type (SFE, Cold Pressed, Organic Solvent, & ... Pharmaceutical, Food Supplements, Fragrance, & Others) - Global Trends ... and segments the Amaranth Seed Oil Market with ... in terms of value. The Amaranth Seed Oil ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... Calif., July 26, 2011 Epitomics, Inc., a ... based on its groundbreaking Rabbit Monoclonal (RabMAb®) technology, ... novel cancer-related antibodies that were developed through a ... Cancer Research. The goal of this partnership is ...
... 26, 2011 Bacterin International Holdings, Inc. ... the development of revolutionary bone graft material and anti-infective coatings ... August 11, at 4:30 p.m. Eastern time to discuss results ... will be issued in a press release after the close ...
Cached Medicine Technology:Epitomics Releases New Antibodies Developed With the National Cancer Institute's Center for Cancer Research 2Bacterin Sets Second Quarter 2011 Conference Call for Thursday, August 11, 2011 at 4:30 p.m. ET 2
(Date:8/29/2014)... According to the latest review published by DailyGossip.org, ... quickly, safely and naturally. The new method promises great efficiency ... too. , Daily Gossip writes in its Flat Belly ... patients how to eliminate the extra pounds, it will also ... comes to body modeling. , The method reveals some ...
(Date:8/29/2014)... 2014 The new review that can be ... a holistic system that will permanently eliminate the symptoms of ... tinnitus can achieve a cure in as fast as 30 ... in only about one week. , The Tinnitus Miracle ... such as mild hearing loss, pain in the ear and ...
(Date:8/29/2014)... Panic attacks are extremely difficult to deal with. ... and fear, which appears with no particular reason, affecting ... affecting relationships. , A panic attack can be caused ... patients can deal with. Anxiety, shortness of breath and ... is extremely important for sufferers, who need a fast ...
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 Dr. ... his plan to rename his practice to Parsa Mohebi ... Restoration has served the needs of hair loss patients ... traveled to its centers in Los Angeles, Beverly Hills, ... surgical and non surgical treatments, many of which Dr. ...
(Date:8/29/2014)... According to a CNN article, entitled Medical ... new study found that those states who legalized medical ... decrease in the number of painkiller overdoses seen. By ... and comparing various states with and without legalized medical ... about a 25% decrease in painkiller prescription overdoses in ...
Breaking Medicine News(10 mins):Health News:Flat Belly Forever Review Exposes the Way to Eliminate Body Fat Easily 2Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2Health News:US Hair Restoration Changes Name to Parsa Mohebi Hair Restoration to Better Reflect Founder 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3
... blood test for early detection of ovarian cancer//. ,Ovarian ... is very difficult to diagnose during its early stages. It ... ovaries, like the surface epithelial cells, germ cells, and the ... ranked 4th in terms of causing deaths due to cancer. ...
... its said that it is better// to go for surgery ... and see if the disease progresses. ,Surgery for treating ... The researchers had conducted he study to see if prostatectomy ... more than watching and waiting the cancer in the prostate ...
... kidney failure in men.// ,The researchers had taken 473 ... a glass a day) and compared their elevated creatinine levels ... than a glass a day of alcohol. The research had ... through a period of 14 years. ,The results of ...
... the May issue of the journal Neurology states that patients// ... to take decisions about their treatments, but those with moderate ... to do so. ,The study also points out that ... in the mare more likely to take competent decisions about ...
... of cholesterol in the blood can increase the risk of ... the recent issue of British Journal of Cancer says that ... of testicular cancer by almost as much as 4.5 % ... ,The Swedish researchers from Karolinska University Hospital had looked into ...
... diet taken during pregnancy not only decides the health// of ... children as well. ,In a study to understand fetal ... about long-term influence on the genetic code of the fetus ... Their research had provided evidence that adverse effects of intrauterine ...
Cached Medicine News:
SkinStation, powered by LHE, is Radiancys flagship product. A powerhouse by design, it incorporates todays most sought after applications all on one user-friendly system ....
Inquire...
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
... Normal and Hypergamma Controls are ... either agarose gels or Sebia's ... Our unique control manufacturing process ... the other serum components, presenting ...
Medicine Products: